HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma
- 31 January 2020
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 135 (13), 1058-1061
- https://doi.org/10.1182/blood.2019003811
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphomaBlood Advances, 2019
- Hematopoietic stem cell transplantation for subcutaneous panniculitis-like T-cell lymphoma: single center experience in an Asian populationInternational Journal of Hematology, 2019
- Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patientsJournal of the American Academy of Dermatology, 2018
- Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndromeNature Genetics, 2018
- Subcutaneous Panniculitis-like T-cell Lymphoma: Immunosuppressive Drugs Induce Better Response than PolychemotherapyActa Dermato-Venereologica, 2017
- Clinical characteristics, differential diagnosis, and treatment outcome of subcutaneous panniculitis-like T-cell lymphoma: a literature review of published Japanese cases.European Journal of Dermatology, 2017
- Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 casesBlood, 2008
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2006
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005